Bayesian Capital Management, LP Repligen Corp Transaction History
Bayesian Capital Management, LP
- $1.01 Billion
- Q1 2024
A detailed history of Bayesian Capital Management, LP transactions in Repligen Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 2,800 shares of RGEN stock, worth $336,392. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,800
Previous 1,162
140.96%
Holding current value
$336,392
Previous $208,000
147.12%
% of portfolio
0.05%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$934 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$613 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$429 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$211 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$176 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.67B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....